about
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressi...
Read More
7.29
-0.17
(-2.28%)
56,821
XNAS Volume
XNAS 06 Mar, 2026 4:30 PM (EST)
Board Meeting
The latest board meeting for Adicet Bio Inc took place on 06 Mar 2026, for the purpose of Adicet Bio Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Adicet Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..